All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier

References

• Lucek RW, Colburn WA. Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 1985;10:38–62
   PubMedGoogle Scholar
• Walters KA, Brain KR. Dermatological and transdermal formulations. New York: Marcel Dekker; 2002:319–39
   Google Scholar
• Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121–8
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Biopharm 2008;70:633–40
   PubMed Web of Science ®Google Scholar
• Stecova J, Mehnert W, Blaschke T, et al. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterization and skin uptake. Pharm Res 2007;24:991–1000
   PubMed Web of Science ®Google Scholar
• Chinsriwongkul A, Opanasopit P, Ngawhirunpat T, et al. Physicochemical properties of lipid emulsions formulated with high-load all-trans retinoic acid. PDA J Pharm Sci Technol 2007;61:461–71
   PubMedGoogle Scholar
• Chern WH, Thakker KD. Development and validation of in vitro release tests for semisolid dosage forms—case study. Dissolut Technol 2003;10:10–15
   Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv 2011;2011:1–9
   Google Scholar
• Wang JJ, Liu KS, Sung KC, et al. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci 2009;38:138–46
   PubMed Web of Science ®Google Scholar
• Yuechao DU. Fabrication and characterization of low crystalline curcumin loaded lipid nanoparticles [dissertation]. New Brunswick (NJ): New Brunswick University; 2011
   Google Scholar
• Driscoll DF, Giampietro K, Wichelhaus DP, et al. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr 2001;20:151–7
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163–72
   PubMed Web of Science ®Google Scholar
• Qingyi XQ, Nakajima M, Liu Z, Shiina T. Soybean-based surfactants and their applications. In: Ng T-B, ed. Soybean – applications and technology. Rijeka, Croatia: InTech; 2011:343–64
   Google Scholar
• Waraho T, Clements DJ, Decker EA. Impact of free fatty acid concentration and structure on lipid oxidation in oil-in-water emulsions. Food Chem 2011;129:854–9
   PubMed Web of Science ®Google Scholar
• Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T, et al. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm Sci Tech 2012;13:150–8
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71–7
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Biopharm 2008;70:633–40
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Eur 2005;17:45–50
   Google Scholar
• Souto EB, Müller RH. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Int J Pharm 2006;61:431–7
   Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131–55
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. Cetylpalmitate-based NLC for topical delivery of Coenzyme Q10: development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007;67:141–8
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, et al. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 2008;128:134–41
   PubMed Web of Science ®Google Scholar
• Wissing SA, Muller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 2002;242:377–9
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170–84
   PubMed Web of Science ®Google Scholar
• Santoyo S, Arellano A, Ygartua P, Martin P. Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int J Pharm 1995;117:219–24
   Web of Science ®Google Scholar
• Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85–97
   Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283–300
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. Int J Pharm 1998;168:221–9
   Web of Science ®Google Scholar
• Teeranachaideekul V, Muller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)—effects of formulation parameters on physicochemical stability. Int J Pharm 2007;340:198–206
   PubMed Web of Science ®Google Scholar